Supplementary Material for JAAD 2025
Published: 5 November 2025| Version 1 | DOI: 10.17632/56s3mnpryv.1
Contributor:
Description
Supplementary Material for "A Single Arm Phase 2 Study of Talimogene Laherparepvec in Patients With Lower Risk Invasive Cutaneous Squamous Cell Cancer" in Journal of the American Academy of Dermatology
Files
Institutions
- University of Arizona
Categories
Non-Melanoma Skin Cancer